Skip to Main content Skip to Navigation
Journal articles

Thymosin beta4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

Abstract : Thymosin beta4 (Tbeta4) is a polypeptide involved in cellular proliferation, differentiation, and migration, over-expressed in several tumor entities. We evaluated its expression and function in 298 newly diagnosed multiple myeloma patients and the murine 5TMM model. Mean Tbeta4 expression was significantly lower in myeloma cells compared to normal plasma cells (P<0.001). The same observation can be made in the 5TMM-mouse model by qRT-PCR and ELISA. Here, Tbeta4 overexpression by lentiviral transduction of 5T33MMvt-cells led to significantly decreased proliferative and migratory capacities and increased sensitivity to apoptosis-induction. Mice injected with Tbeta4 over-expressing myeloma cells showed a longer survival compared to mice injected with controls (88,9 vs. 65,9 days, P<0.05). In 209 MM patients treated with high-dose therapy and autologous stem cell transplantation, expression of Tbeta4 below the median was associated with a significantly shorter event free survival (37.6 vs. 26.2 months, P<0.05). In conclusion, our results indicate a possible tumor suppressive function of Tbeta4.
Document type :
Journal articles
Complete list of metadatas

Cited literature [17 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00453267
Contributor : Monique Frei <>
Submitted on : Thursday, February 4, 2010 - 11:28:53 AM
Last modification on : Thursday, June 4, 2020 - 11:46:02 AM
Long-term archiving on: : Friday, June 18, 2010 - 6:49:48 PM

Files

2010_1Haematologica0307.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Jo Caers, Dirk Hose, Ine Kuipers, Tomas Jan Bos, Els van Valckenborgh, et al.. Thymosin beta4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.. Haematologica, Ferrata Storti Foundation, 2010, 95 (1), pp.163-7. ⟨10.3324/haematol.2009.006411⟩. ⟨inserm-00453267⟩

Share

Metrics

Record views

257

Files downloads

662